Charles Schwab Investment Management Inc Cocrystal Pharma, Inc. Transaction History

Charles Schwab Investment Management Inc

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2021 Nov 16, 2021	SELL	$1.01 - $1.25 $39,626 - $49,042	-39,234 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$1.08 - $2.14 $42,372 - $83,960	39,234 New	39,234 $50,000

Ticker COCP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,122,420
Market Cap $21.3M
Description
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company ...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.